Latest News - Visual & Sensory Disturbances

Tuesday, July 25, 2017 | Research and Publications, Visual & Sensory Disturbances

Largest CTE Study in Football Players to Date Finds Pathological Diagnosis in 110 out of 111 NFL Players

The already compelling evidence tying football to chronic traumatic encephalopathy (CTE) is now even stronger, with the publication of findings from the largest study yet to evaluate the brains of dec…

Read the full story

Thursday, June 22, 2017 | Stroke & Cerebrovascular, Visual & Sensory Disturbances

Dysport Approved for Lower Limb Spasticity

The FDA has expanded the indication of Dysport (abobotulinumtoxinA, Ipsen Biopharmaceuticals) to include lower limb spasticity. In a Phase 3 study, adult patients treated with Dysport following a stro…

Read the full story

Wednesday, January 25, 2017 | Research and Publications, Visual & Sensory Disturbances

Validation Study for Potential CTE Detection Blood Test Initiated

Researchers with Exosome Sciences, Inc., are initiating a clinical study involving retired NFL players and a data-supported biomarker candidate to detect and monitor Chronic Traumatic Encephalopathy (…

Read the full story

Wednesday, November 16, 2016 | Healthcare Trends, Research and Publications, Visual & Sensory Disturbances

AMA Takes Policy Steps to Encourage Further CTE Research

The American Medical Association (AMA) has recently adopted new policies urging further research into the detection, causes, and prevention of head injuries. In particular, the policies encourage effo…

Read the full story

Wednesday, September 28, 2016 | FDA Approval/Clearance, Visual & Sensory Disturbances

FDA Clears Handheld TBI Assessment Device

The FDA has cleared BrainScope’s newest device for the assessment of traumatic brain injury (TBI), the Ahead 300. Developed in partnership with the US Department of Defense, the Ahead 300 provid…

Read the full story